Michael Franken is President & Biosimilars Busines at MOMENTA PHARMACEUTICALS INC (MNTA). They have made 1 open-market trade across 1 company since 2014, most recently 2015-12-11.
CIK 0001551439
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MNTA | 37,968 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2015-12-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MNTA | SELL · 10b5-1 | 2015-12-11 | 2015-12-14 | $15.84 | $8K | -10.8% | -10.8% | -39.3% |
| MNTA | SELL · 10b5-1 | 2015-09-11 | 2015-09-15 | $18.92 | $10K | -10.8% | -2.5% | -2.5% |
| MNTA | SELL | 2015-08-10 | 2015-08-14 | $22.36 | $447K | -10.8% | -2.5% | -2.5% |
| MNTA | SELL · 10b5-1 | 2015-06-11 | 2015-06-15 | $22.37 | $11K | -10.8% | -2.5% | -2.5% |
| MNTA | SELL · 10b5-1 | 2015-03-11 | 2015-03-13 | $14.71 | $8K | -10.8% | -2.5% | -2.5% |
| MNTA | SELL · 10b5-1 | 2014-12-11 | 2014-12-12 | $12.29 | $25K | -10.8% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.